Photo from wikipedia
Introduction The risk of osteonecrosis of the jaw is greater for patients receiving intravenous bisphosphonates for cancer than for patients receiving oral bisphosphonates for osteoporosis or Paget’s disease. Materials and… Click to show full abstract
Introduction The risk of osteonecrosis of the jaw is greater for patients receiving intravenous bisphosphonates for cancer than for patients receiving oral bisphosphonates for osteoporosis or Paget’s disease. Materials and Methods This article provides a review of the treatment of Bisphosphonate induced osteonecrosis of jaws. Conclusion Bisphonates associated jaw necrosis and its relation to dentisitry and maxillofacial surgery has become common now a days. Proper diagnosis and treatment may help the patients health getting worsen.
Journal Title: Journal of Maxillofacial and Oral Surgery
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!